Staff Profile
Edit
Career Summary
Qualifications
- PhD (Medicine), University of Sydney, 16/08/2007
- Bachelor of Science (Biotechnology)(Honours), University of Newcastle, 27/11/2000
Research
Research keywords
- breast cancer
- gene expression
- miRNA
- p53
Research expertise
Kelly Avery-Kiejda's research interests are:
- understanding the molecular mechanisms of cancer development and the resistance of cancer to treatment
- understanding how p53 function becomes de-regulated in cancer, in particular, melanoma and breast cancer
- the role of miRNAs in advanced breast cancer
Languages
- English
Fields of Research
| Code | Description | Percentage |
|---|---|---|
| 111200 | Oncology And Carcinogenesis | 40 |
| 111201 | Cancer Cell Biology | 30 |
| 111203 | Cancer Genetics | 30 |
Memberships
Body relevant to professional practice.
- Member - Australian Society for Medical Research (ASMR)
- Member - The Australian Microarray and Associated Technologies Association
- Member - Research Enabling Committee of the Hunter Translational Cancer Research Unit
- Member - Hunter Medical Research Institute Disaster Sub-Plan Committee
- Member - Australian Society for Biochemistry and Molecular Biology
Committee/Associations (relevant to research).
- Member - 2013 ASMR Gala Dinner Organising Committee, 6th June, Merewether Surfhouse, Newcastle
- Member - Organising committee for the 2013 Translational Cancer Research Conference, Newcastle, Australia
- Member - 2012 ASMR Gala Dinner Organising Committee, 7th June, Customs House, Newcastle
- Member - Organising committee for the 2012 5th Annual Hunter Cancer Research Symposium, Newcastle, NSW, Australia. Held on 2nd November 2012.
- Member - Organising committee for the 2012 ASMR Cocktail Party, Newcastle, NSW, Australia. Held on the 21st September,
- Member - Organising committee for the 4th Annual Hunter Medical Research Institute Cancer Research Program Symposium, Newcastle, NSW, Australia. Held on 4th November, 2011.
Conference Chair
- Session chair at the 2012 5th Annual Hunter Cancer Research Symposium, Newcastle, NSW, Australia. Held on 2nd November 2012.
- Session chair at the 2011 4th Annual Hunter Medical Research Institute Cancer Research Program Symposium, Newcastle, NSW, Australia. Held on 4th November, 2011.
NHMRC Committee
- Member - The NHMRC Postdoctoral Reference Group
National & International Standards Committees.
- Member - Institutional Biosafety Committee
Appointments
| Cameron Melanoma Research Fellow Calvary Mater Newcastle Hospital (Australia) | 01/08/2005 - 01/09/2009 |
| Hunter Translational Cancer Research Unit Fellow University of Newcastle (Australia) | 01/03/2012 - 01/03/2013 |
Awards
Recognition.
| 2012 | Emerging research leaders program University of Newcastle (Australia) Program run by Pro Vice Chancellor (Research) to mentor future research leaders |
|---|---|
| 1999 | Deans Commendation List University of Newcastle (Australia) To recognise well performing undergraduate students |
| 1998 | Most Outstanding Performance in the subject Cell and Molecular Biology University of Newcastle (Australia) To recognise the most outstanding performer in the subject Cell and Molecular Biology |
Research Award.
| 2010 | HMRI PULSE Education Prize PULSE (Australia) |
|---|---|
| 2006 | HMRI Translational Cancer Research Conference Early Career Researcher Poster Award Hunter Medical Research Institute (Australia) For the best Early Career researcher poster at the bi-annual Hunter Medical Research Institute (HMRI) Conference on Translational Cancer Research |
Scholarship
| 2001 | Australian Postgraduate Award University of Sydney (Australia) |
|---|---|
| 2001 | Millennium Foundation Stipend Enhancement Grant The Millennium Foundation, Sydney, NSW, Australia (Australia) The Millennium Foundation provided a top-up scholarship to recognize outstanding students |
Invitations
| Small p53 Isoforms- BIG Implications for Prognosis and Treatment Response in Cancer. 22nd Annual Queenstown Molecular Biology Meeting: Cancer Biology Satellite. 26-27th August, 2012, Queenstown, New Zealand (Invited Presenter) | 2012 |
| MicroRNA expression profiling in triple-negative breast cancer. The 9th International RNAi, MicroRNAs and Single Cell Biology Meeting, 1st-2nd May, 2012, Boston , United States (Invited Presenter) | 2012 |
| MicroRNA expression profiling in triple-negative breast cancer Pharmacy Australia Centre of Excellence (PACE), School of Pharmacy, The University of Queensland, Australia (Invited Presenter) | 2011 |
| Small isoforms of p53: Do they contribute to melanoma chemoresistance? Research Seminar Series for the Melanoma Foundation, 15th August 2008., Sydney, NSW, Australia (Invited Presenter) | 2008 |
| The role of p53 variants in human melanoma The Melanoma and Skin Cancer Research Institute (MASCRI) Seminar Series, 20th October 2006, Sydne y, NSW, Australia (Invited Presenter) | 2006 |
Administrative
Administrative expertise
Journal Peer Review
- Reviewer for Neoplasia, Int J Cancer and the prominent AACR journals Clin Cancer Res and Mol Cancer Ther.
Grant Peer review
- External assessor for NHMRC project grant funding rounds
- Assessor for the Hunter Translation Cancer Research Unit pilot project grant rounds in 2012
Teaching
Teaching expertise
Dr Avery-Kiejda is a full-time research academic. Currently, Dr Avery-Kiejda is the mentor of an early career postdoctoral fellow and the supervisor of 4 PhD candidates.
- She has been the primary and co-supervisor of 2 Honours students (received 1st class Honours).
- She was the sole supervisor of 3 undergraduate students for their 3rd year projects in the Biotechnology and Biomedical Science degree
- She was a demonstrator for the subject Molecular Genetics (2000).
Edit
- Indicates that the researcher may be seeking students for this project.The function of the delta-40p53 isoform in breast cancer.$30,000
miRNA regulation of growth, invasion and treatment response in triple negative breast cancer$10,000
The Hunter Cancer Biobank (HCB): Maximising community value through validation, annotation and distribution throughout NSW$292,300
p53 isoforms in breast cancer - MM Sawyer Estate Scholarship$75,000
Small p53 isoforms, BIG implications for treatment response in breast cancer$30,000
2011 Emerging Research Leaders Program$15,000
Ninth International NRAi, MicroRNAs & Single Cell Biology - 2012, Hilton Garden Inn, Waltham, Massachusetts, USA, 1 - 2 May 2012$2,000
p53 isoforms, a prognostic indicator in breast cancer?$45,000
PULSE Education Prize$4,000
Annual meeting fo the Australasian Microarray & Associated Technologies Association (AMATA), Shine Dome in Canberra, 9 - 12 October 2011$1,375
The identification of microRNA's as therapeutic targets for the treatment of advanced breast cancer$21,600
Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$272,000
Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$75,000
Targeting p53 isoforms in human melanoma$30,000
The microRNA signature of endoplasmic reticulum stress in melanoma$10,000
Characterization of p53 isoforms in human melanoma: do they play a role in chemoresistance?$75,000
The role of p53 Isoforms in chemoresistances of human melanoma$20,000
The role of p53 isoforms in chemoresistance of human melanoma$10,000
Cameron Fellowship in Melanoma Research$332,000
Australian Postgraduate Award$64,750
Millennium Foundation Stipend Enhancement Grant$18,000
Grants and Funding
Summary
| Number of grants | 21 |
|---|---|
| Total funding | $1,433,025 |
For project grants received where the lead institution is other than the University of Newcastle, details are shown in italics.
Click on a grant title below to expand the full details for that specific grant.
2013 (2 grants)
The function of the delta-40p53 isoform in breast cancer.$30,000
Funding Body: Hunter Medical Research Institute
| Project Team | ||
|---|---|---|
| Doctor Kelly Kiejda, Miss Brianna Morten, Professor Rodney Scott | ||
| Scheme | Role | |
| Project Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $30,000 | 2013 | 2013 |
| GNo:G1300583 | ||
miRNA regulation of growth, invasion and treatment response in triple negative breast cancer$10,000
Funding Body: Hunter Medical Research Institute
| Project Team | ||
|---|---|---|
| Doctor Kelly Kiejda, Miss Andrea Mathe | ||
| Scheme | Role | |
| Project Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $10,000 | 2013 | 2014 |
| GNo:G1300728 | ||
2012 (5 grants)
The Hunter Cancer Biobank (HCB): Maximising community value through validation, annotation and distribution throughout NSW$292,300
Funding Body: Cancer Institute NSW
| Project Team | ||
|---|---|---|
| Professor John Forbes, Conjoint Professor Stephen Ackland, Professor Rodney Scott, Conjoint Associate Professor Barbara Young, Professor Hubert Hondermarck, Conjoint Professor Leonie Ashman, Professor Xu Dong Zhang, Doctor Kelly Kiejda, Doctor Nikki Verrills, Doctor Jennette Sakoff, Ms Janine Lombard, Doctor Jude Weidenhofer, Doctor Pradeep Tanwar | ||
| Scheme | Role | |
| Infrastructure Grants | Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $292,300 | 2012 | 2014 |
| GNo:G1200798 | ||
p53 isoforms in breast cancer - MM Sawyer Estate Scholarship$75,000
Funding Body: Hunter Medical Research Institute
| Project Team | ||
|---|---|---|
| Doctor Kelly Kiejda, Professor Rodney Scott | ||
| Scheme | Role | |
| Mary Minto Sawyer Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $75,000 | 2012 | 2014 |
| GNo:G1200615 | ||
Small p53 isoforms, BIG implications for treatment response in breast cancer$30,000
Funding Body: Hunter Medical Research Institute
| Project Team | ||
|---|---|---|
| Doctor Kelly Kiejda, Professor Rodney Scott | ||
| Scheme | Role | |
| Project Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $30,000 | 2012 | 2014 |
| GNo:G1200322 | ||
2011 Emerging Research Leaders Program$15,000
Funding Body: University of Newcastle
| Project Team | ||
|---|---|---|
| Doctor Kelly Kiejda | ||
| Scheme | Role | |
| Emerging Research Leaders Program | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $15,000 | 2012 | 2012 |
| GNo:G1200817 | ||
Ninth International NRAi, MicroRNAs & Single Cell Biology - 2012, Hilton Garden Inn, Waltham, Massachusetts, USA, 1 - 2 May 2012$2,000
Funding Body: University of Newcastle - Faculty of Health
| Project Team | ||
|---|---|---|
| Doctor Kelly Kiejda | ||
| Scheme | Role | |
| Travel Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $2,000 | 2012 | 2013 |
| GNo:G1200588 | ||
2011 (3 grants)
p53 isoforms, a prognostic indicator in breast cancer?$45,000
Funding Body: Hunter Medical Research Institute
| Project Team | ||
|---|---|---|
| Doctor Kelly Kiejda, Professor Rodney Scott, Professor John Forbes | ||
| Scheme | Role | |
| Breast Cancer Project Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $45,000 | 2011 | 2011 |
| GNo:G1001006 | ||
PULSE Education Prize$4,000
Funding Body: Hunter Medical Research Institute
| Project Team | ||
|---|---|---|
| Doctor Kelly Kiejda | ||
| Scheme | Role | |
| PULSE Education Prize | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $4,000 | 2011 | 2011 |
| GNo:G1001021 | ||
Annual meeting fo the Australasian Microarray & Associated Technologies Association (AMATA), Shine Dome in Canberra, 9 - 12 October 2011$1,375
Funding Body: University of Newcastle - Faculty of Health
| Project Team | ||
|---|---|---|
| Doctor Kelly Kiejda | ||
| Scheme | Role | |
| Travel Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $1,375 | 2011 | 2012 |
| GNo:G1100938 | ||
2010 (1 grants)
The identification of microRNA's as therapeutic targets for the treatment of advanced breast cancer$21,600
Funding Body: Hunter Medical Research Institute
| Project Team | ||
|---|---|---|
| Doctor Kelly Kiejda, Professor Rodney Scott, Professor John Forbes | ||
| Scheme | Role | |
| Research Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $21,600 | 2010 | 2010 |
| GNo:G0900144 | ||
2009 (4 grants)
Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$272,000
Funding Body: Cancer Council NSW
| Project Team | ||
|---|---|---|
| Professor Xu Dong Zhang, Conjoint Professor Peter Hersey, Doctor Kelly Kiejda | ||
| Scheme | Role | |
| Research Grant | Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $272,000 | 2009 | 2011 |
| GNo:G0188913 | ||
Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$75,000
Funding Body: Cancer Australia
| Project Team | ||
|---|---|---|
| Doctor Kelly Kiejda, Professor Xu Dong Zhang, Conjoint Professor Peter Hersey | ||
| Scheme | Role | |
| Priority-driven Collaborative Cancer Research | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $75,000 | 2009 | 2010 |
| GNo:G0188914 | ||
Targeting p53 isoforms in human melanoma$30,000
Funding Body: Calvary Mater Newcastle
| Scheme | Role | |
|---|---|---|
| Project Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $30,000 | 2009 | 2009 |
| GNo:174562457 | ||
The microRNA signature of endoplasmic reticulum stress in melanoma$10,000
Funding Body: Calvary Mater Newcastle
| Scheme | Role | |
|---|---|---|
| Project Grant | Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $10,000 | 2009 | 2009 |
| GNo:174562465 | ||
2007 (3 grants)
Characterization of p53 isoforms in human melanoma: do they play a role in chemoresistance?$75,000
Funding Body: Cure Cancer Australia Foundation
| Scheme | Role | |
|---|---|---|
| Research Grant | Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $75,000 | 2007 | 2007 |
| GNo:174562473 | ||
The role of p53 Isoforms in chemoresistances of human melanoma$20,000
Funding Body: Hunter Medical Research Institute
| Project Team | ||
|---|---|---|
| Professor Xu Dong Zhang, Doctor Kelly Kiejda | ||
| Scheme | Role | |
| Project Grant | Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $20,000 | 2007 | 2007 |
| GNo:G0187239 | ||
The role of p53 isoforms in chemoresistance of human melanoma$10,000
Funding Body: Calvary Mater Newcastle
| Scheme | Role | |
|---|---|---|
| Project Grant | Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $10,000 | 2007 | 2007 |
| GNo:174562481 | ||
2006 (1 grants)
Cameron Fellowship in Melanoma Research$332,000
Funding Body: Melanoma and Skin Cancer Research Institute
| Scheme | Role | |
|---|---|---|
| fellowship | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $332,000 | 2006 | 2009 |
| GNo:174562489 | ||
2001 (2 grants)
Australian Postgraduate Award$64,750
Funding Body: Department of Education, Training & Youth Affairs
| Scheme | Role | |
|---|---|---|
| Scholarship support for PhD | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $64,750 | 2001 | 2004 |
| GNo:174562497 | ||
Millennium Foundation Stipend Enhancement Grant$18,000
Funding Body: Millennium Foundation
| Scheme | Role | |
|---|---|---|
| Stipend enhancement grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $18,000 | 2001 | 2004 |
| GNo:174562505 | ||
Edit
Research Supervision
| Number of current supervisions | 4 |
|---|---|
| Total current UoN PhD EFTSL | 1.15 |
For supervisions undertaken at an institution other that the University of Newcastle, details are shown in italics, and the institution name is listed below the program name.
Current Supervision
| Commenced | Proposed Completion | Program | Supervisor Type | Research Title |
|---|---|---|---|---|
| 2012 | 2016 | PhD (Medical Genetics) | Co-Supervisor | The Functional Role of MicroRNAs Associated With Lymph Node Metastasis in Triple Negative Breast Cancer |
| 2012 | 2016 | PhD (Medical Genetics) | Principal Supervisor | p53 Isoforms in Breast Cancer |
| 2010 | 2016 | PhD (Medical Genetics) | Co-Supervisor | Role of Tandem Repeats in Genetic Susceptibility to Breast Cancer |
| 2009 | 2013 | PhD (Medical Genetics) | Co-Supervisor | The Contribution of Genetic Susceptibility to Breast Cancer |
Edit
Dr Kelly Kiejda
| Work Phone | 4042 0309 |
|---|---|
| Fax | 4042 0031 |
| Kelly.Kiejda@newcastle.edu.au | |
| Position | Research Fellow Information Based Medicine School of Biomedical Sciences and Pharmacy Faculty of Health and Medicine |
| Focus Area | Medical Genetics |
| Office | Rm 3104, Lvl 3, West, Hunter Medical Research Institute , Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305 |
| URL: | www.newcastle.edu.au/profile/kelly-kiejda |
